Esperion Class Attys Nab $6M In Fees From $18M Settlement
The attorneys who secured an $18.25 million settlement for Esperion Therapeutics investors in a securities class action will be awarded a 32.5% portion of the settlement amount plus expenses in the...To view the full article, register now.
Already a subscriber? Click here to view full article